222
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy

ORCID Icon, , , , , , , , , ORCID Icon, , , , & ORCID Icon show all
Pages 750-752 | Received 25 Sep 2022, Accepted 21 Jan 2023, Published online: 01 Feb 2023
 

Disclosure statement

Annie Im has performed consulting from Abbvie and CTI Biopharma and received research funding from Incyte. Alison Sehgal has received research funding from Kite/Gilead, Juno/BMS and Milltenyiz. Michael Boyiadzis is currently an adjunct professor of Medicine at the University of Pittsburgh and an employee of Genentech.

Additional information

Funding

K.L. is supported by the NIH TL1 [TR001858].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.